Amylx Pharmaceuticals Inc vs Dicks Sporting Goods Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Dicks Sporting Goods Inc trades at $206.29 (market cap $18.35B). The key difference: Dicks Sporting Goods Inc is far larger — about 7× Amylx Pharmaceuticals Inc's market cap, and Dicks Sporting Goods Inc pays a 2.44% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | DKS | |
|---|---|---|
Market Cap | $2.64B | $18.35B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $239.17 |
52-Week Low | $7.82 | $187.78 |
Enterprise Value | $2.39B | $25.14B |
Dividend Yield | — | 2.44% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →